The Pulmonary Hypertension Association (PHA) and Washington University School of Medicine, Continuing Medical Education are pleased to announce our latest continuing medical education (CME) initiative — live medical education on demand. This program allows you to design a CME meeting that meets your medical community’s educational needs concerning pulmonary arterial hypertension (PAH).
Steps for Requesting a Program
For Medical Professionals Only
Attend a Program
Interested in attending an event? Check out the schedule and register.

Target Audience
This activity has been designed for pulmonologists, cardiologists, rheumatologists, internists, and primary care physicians, as well as nurses, physician assistants, and other allied health professionals who help care for patients with PAH.
Educational Objectives
This CME program is designed to improve competence, performance, and patient care practices by instructing clinicians in the highest quality of care for patients with PAH. At the conclusion of the program, participants should be able to:
- Accurately diagnose patients through comprehensive screening and early recognition of symptoms
- Evaluate the patient’s condition and prescribe long-term optimal management, including knowing when and how to treat and when to consult with colleagues at an established PAH center
Accreditation and Credit Designation
This live activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Washington University School of Medicine, Continuing Medical Education and the Pulmonary Hypertension Association. Washington University is accredited by the ACCME to provide continuing medical education for physicians.
Washington University designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Program Costs
These programs, administered within ACCME guidelines and according to the specifications outlined, are offered at no cost to pulmonologists, cardiologists, rheumatologists, internists, and primary care physicians, as well as nurses, physician assistants, and other allied health professionals who help care for patients with PAH.
DIAMOND SUPPORTER
|
PLATINUM SUPPORTER
|
GOLD SUPPORTER
|
SILVER SUPPORTER
|
| Actelion Pharmaceuticals US, Inc. |
Gilead Sciences, Inc. |
United Therapeutics Corporation |
Bayer HealthCare |
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.